Chief Executive Officer
Thu, Oct 15, 2020
Oct 15
5,000 shares @ $34.46
Decreased holdings by -0.50%
49th largest trade (out of 180)
Trade made by an officer
43% win rate · +2.1% median edge vs SPY (7 trades, 90-day · small sample)
Price 9% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology